Minerva Surgical Company Description
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States.
The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.
Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices.
The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Country | United States |
Founded | 2008 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 174 |
CEO | Darrin Hammers |
Contact Details
Address: 4255 Burton Drive Santa Clara, Delaware 95054 United States | |
Phone | 855 646 7874 |
Website | minervasurgical.com |
Stock Details
Ticker Symbol | UTRS |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US60343F1066 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Darrin Hammers | Chief Executive Officer |
Greg Simbro | Vice President of Finance |
Erik Reese | Vice President of Sales |
Wendy Bowman | Vice President of Human Resources |
Dr. Evgueni V. Skalnyi M.D. | Chief Medical Officer |
Brent Palmisano | Chief Commercial Officer |
Joanne Long | Vice President of Corporate Controller |